KRRO

Korro Bio, Inc.NASDAQHealthcare

$14.00+10.67%ClosedMarket Cap: $131.6M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-13	Cantor Fitzgerald	—	Overweight	—
2026-03-13	Raymond James	—	Outperform	—
2026-02-19	Clear Street	—	Buy	—
2026-02-17	William Blair	—	Outperform	—
2026-01-29	Piper Sandler	—	Overweight	—
2026-01-29	HC Wainwright & Co.	—	Buy	—
2026-01-29	Chardan Capital	—	Buy	—
2026-01-28	Oppenheimer	—	Outperform	—
2026-01-28	Cantor Fitzgerald	—	Overweight	—
2025-11-14	Jones Trading	—	Hold	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-6.51	$1.5M	4
Sun Dec 31	$-6.71	$2.7M	6
Mon Dec 31	$-8.08	$10.7M	4
Tue Dec 31	$-8.63	$38.6M	2